The Clorox Company (NYSE:CLX) Shares Sold by Radnor Capital Management LLC

Radnor Capital Management LLC lessened its position in shares of The Clorox Company (NYSE:CLX) by 2.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,312 shares of the company’s stock after selling 80 shares during the quarter. Radnor Capital Management LLC’s holdings in Clorox were worth $538,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Insight Folios Inc boosted its position in Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after buying an additional 63 shares during the last quarter. SPC Financial Inc. boosted its holdings in shares of Clorox by 2.2% in the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after acquiring an additional 75 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its stake in shares of Clorox by 17.2% in the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after acquiring an additional 75 shares during the period. Empower Advisory Group LLC raised its holdings in shares of Clorox by 4.5% during the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after purchasing an additional 78 shares during the last quarter. Finally, Aviance Capital Partners LLC lifted its position in Clorox by 2.7% during the third quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after purchasing an additional 80 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 0.4 %

Shares of NYSE CLX opened at $158.43 on Thursday. The firm has a market cap of $19.61 billion, a price-to-earnings ratio of 55.20, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The company’s 50-day simple moving average is $164.48 and its 200-day simple moving average is $156.16. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the firm posted $0.49 EPS. Clorox’s revenue was up 27.0% compared to the same quarter last year. Equities analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.08%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.03%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price target for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. JPMorgan Chase & Co. raised their target price on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Evercore ISI decreased their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $155.00 to $157.00 in a research note on Tuesday, January 7th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $157.46.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.